Autres langues Procaps Group S.A.

Actions

PROC

LU2376511205

Marché Fermé - Nasdaq Autres places de cotation 22:30:00 01/05/2024			Varia. 5j.	Varia. 1 janv.
2,775 ^USD	+5,92 %		+0,91 %	-31,82 %

04/03	Procaps Group S.A. annonce la formation d'un Comité Stratégique pour explorer les alternatives de création de valeur	CI
04/03	Procaps Group annonce la formation d'un comité stratégique pour explorer les alternatives de création de valeur	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Procaps Group Delays Filing of Annual Report on Form 20-F	01/05
Procaps Announces Formation of Strategic Committee to Explore Value Creation Alternatives	04/03
Procaps Group S.A. Announces Formation of Strategic Committee to Explore Value Creation Alternatives	04/03
Procaps Group Announces Formation of Strategic Committee to Explore Value Creation Alternatives	04/03
Hoche Partners Pharma Holding S A Issues a Letter to Procaps Group, S A	20/02
Procaps Issues Shareholder Letter from New CEO	05/02
Declaration of Voting Results by Procaps Group, S A	24/01
Procaps Group – Notice to Shareholders	16/01
Hoche Partners Sends a Letter to Procaps Group	12/01
Procaps Group Reports Third Quarter 2023 Results	26/12
Procaps Group S.A. Provides Earnings Guidance for the Full Year 2023	26/12
Procaps S A : and subsidiaries (The Group) - Form 6-K	26/12
Procaps S A : Group Reports Third Quarter 2023 Results - Form 6-K	26/12
Procaps Group S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	26/12
Tranche Update on Procaps Group S.A.'s Equity Buyback Plan announced on June 1, 2023.	26/12
Statement from the Board of Directors of Procaps Group	22/12
Procaps Group Teams Up With Genomma Lab to Manufacture, Market Softgel Products in Latin America	30/11
Procaps Group and Genomma Lab Announce a Strategic Agreement to Manufacture and Market Softgel Products in Latin America	30/11
Procaps Group and Genomma Lab Announce a Strategic Agreement to Manufacture and Market Softgel Products in Latin America	29/11
Procaps Group and Genomma Lab Announce Strategic Agreement to Manufacture and Market Softgel Products in Latin America	29/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Procaps Group S.A.

Actions

PROC

LU2376511205

Autres langues

Filtres